By Amy Furlong: All new pharmaceutical products must go through comprehensive testing to thoroughly assess their effect on patients before being approved for release to the market.
ERT
- Articles
-
White Papers
- Inter-visit Variability of Spirometry and Diffusion
- Inter-visit Variability of Spirometry and Diffusion
- TUFTS Cardiac Safety Report
- TUFTS Cardiac Safety Report
- TUFTS Cardiac Safety Report
- TUFTS Cardiac Safety Report
- Testing the Usability of e-PRO Translations during Linguistic Validation: Presented at ISPOR November 2010, Prague
- eC-SSRS Suicidality Poster Presented at the ISCTM
-
Webinars
- Prospective Assessment of Suicidality - A Review and Discussion of the Recent FDA Draft Guidance
- Prospective Assessment of Suicidality - A Review and Discussion of the Recent FDA Draft Guidance
- Prospective Assessment of Suicidality - A Review and Discussion of the Recent FDA Draft Guidance
- Prospective Assessment of Suicidality - A Review and Discussion of the Recent FDA Draft Guidance
- Prospective Assessment of Suicidality - A Review and Discussion of the Recent FDA Draft Guidance
- Prospective Assessment of Suicidality - A Review and Discussion of the Recent FDA Draft Guidance
- Cardiac Safety - Best Science, Best Value
- Prospective Suicidality Monitoring in Clinical Trials
